BiotechnologyCloudChi-Biotech Launches Free-To-Use Next-Gen FANSe-Based Sequencing Analysis Solution on Amazon’s Cloud Platform
Chi-Biotech Co. Ltd. (“Chi-Biotech” or “the Company”) announced that after two years of efforts, it has successfully deployed its FANSe-based next-generation sequencing analysis solution on Amazon Web Services (AWS). The free-of-charge, accurate solution is now available to customers globally, which can significantly reduce costs and increase efficacy for precision medicine and scientific research around the globe. Next-generation sequencing (NGS) parallelly sequences billions of DNA fragments. Aligning these reads to reference genome is the first step...